FTV:NYSEFortive Corporation Analysis
Data as of 2026-03-11 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Fortive (FTV) is trading at $55.82, well above its DCF‑derived fair value of $36.43, suggesting the stock is currently overvalued despite a bullish technical backdrop where the 20‑day SMA ($57.96) sits above both the 50‑day ($56.40) and 200‑day ($52.30) averages. The RSI at 42.7 points to modest momentum, while the MACD histogram is negative, indicating short‑term bearish pressure as the price hovers just above the identified support level of $54.97. Recent earnings beat (adjusted EPS $0.90 vs. $0.83 expectation) and an upbeat 2026 EPS outlook (forward EPS $3.18) have reinforced confidence, reflected in an “Extreme Greed” sentiment index reading of 76.91. However, volume is decreasing, and volatility remains high at roughly 42% over the past 30 days, which amplifies downside risk. The company’s dividend yield of 0.47% is modest, but the low payout ratio (≈17%) and strong operating cash flow ($1.08 bn) support dividend sustainability. Balance‑sheet metrics show a debt‑to‑equity of 51% with $3.31 bn of debt offset by $0.38 bn of cash, indicating manageable leverage but limited financial flexibility. Overall, while the fundamentals are solid and growth prospects appear reasonable, the current price premium and technical signals advise caution.
Market Outlook
Short Term
< 1 yearKey Factors
- Price near technical support with bearish MACD histogram
- High recent volatility and decreasing trading volume
- Current market price exceeds intrinsic DCF valuation
Medium Term
1–3 yearsKey Factors
- Earnings beat and strong forward EPS guidance
- Sustainable dividend supported by low payout ratio
- Improving valuation metrics as forward PE contracts to 17.5x
Long Term
> 3 yearsKey Factors
- Diversified product portfolio across industrial and healthcare segments
- Stable cash generation and manageable leverage
- Long‑term growth driven by digital and connected‑worker solutions
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.